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Absence of Vsx1 expression in the normal and damaged mouse
cornea
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Purpose: To examine the expression of visual system homeobox 1 (Vsx1) in the mouse cornea and its potential role in
the corneal wound response pathway.
Methods: Expression of Vsx1 was examined by quantitative reverse-transcription PCR (qRT–PCR) in corneal tissue from
developing and adult mice and from mice that had undergone alkali-burn corneal wounding. Immunolabeling and Vsx1
knock-in reporter gene expression in wild type and Vsx1 null-mice were used to confirm the qRT–PCR data.
Results: Using qRT–PCR, Vsx1 expression was not detected in either the postnatal or adult mouse cornea or in corneas
following wounding. This qRT–PCR data was supported by the absence of specific Vsx1 immunolabeling and Vsx1 knock-
in reporter expression in untreated and wounded corneas.
Conclusions: In mice, Vsx1 mRNA, protein or reporter gene expression is not detected in the normal or damaged cornea.
These results make it uncertain what role VSX1/Vsx1 plays in corneal biology. Future experiments examining the
pathogenicity of VSX1 mutations associated with corneal dystrophy are required to rule out species differences and possible
non-cell autonomous roles for VSX1 in the cornea.
Visual  system  homeobox  1  (Vsx1)  is  a  paired-like
homeobox gene, initially described in the goldfish retina [1]
and later as RINX in the human retina [2]. In mice, Vsx1
expression is first detected in the developing retinal inner
nuclear layer (INL) cells at postnatal day 5 [3]. In the mature
retina, Vsx1 expression persists in the INL and is expressed in
a subset ON and OFF cone bipolar cells [3,4]. Vsx1 has been
found to play a central role in bipolar cell differentiation. In
Vsx1 null mice bipolar cells are specified properly, but exhibit
terminal  differentiation  defects  characterized  by  reduced
levels of bipolar marker expression in OFF cone bipolar cells
[4,5].  Accompanying  these  defects  in  bipolar  cell  marker
expression, Vsx1 null mice have visual signaling defects that
include a reduced electroretinogram b-wave and reduced OFF
ganglion cell signaling, indicating a role for Vsx1 in OFF
bipolar cell function.
Despite the well characterized role for Vsx1 in mouse
retinal bipolar cells, the role of VSX1/Vsx1 in human corneal
disease  is  controversial.  Eight  dominant  VSX1  missense
mutations associated with Posterior Polymorphous Corneal
Dystrophy  1  (PPCD1;  OMIM  122000)  and  keratoconus
(OMIM 148300) have been identified [6-9]. Several of these
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mutations are compelling in that they alter highly conserved
amino  acid  residues  and/or  are  accompanied  by
electroretinogram  defects  indicative  of  retinal  bipolar  cell
dysfunction as is observed in Vsx1 null mice [4,5]. In contrast,
other  studies  examining  sporadic  or  familial  keratoconus
[10-13]  and  PPCD1  [14-16]  have  failed  to  reveal  VSX1
mutations. In addition, while VSX1 corneal expression has
been reported in adult [17] and neonatal [18] human cornea,
other studies in mouse [3] and human [7,16,19] have failed to
detect  VSX1/Vsx1  expression  in  the  mature  cornea.
Interestingly, it has been reported that VSX1 is upregulated in
human  and  mouse  corneal  stromal  keratocytes  following
corneal wounding [19]. This has led to the suggestion that
VSX1 functions as a corneal damage response gene and that
corneal  dystrophies  associated  with  changes  in  VSX1  are
linked to defects in the corneal wound-healing pathway [19].
To investigate the role of Vsx1 in the mouse cornea, we
undertook a quantitative RT–PCR (qRT–PCR) approach to
characterize the expression of Vsx1 in the developing and
mature mouse cornea. Vsx1 expression was also examined in
corneal tissue from mice that underwent alkali-burn corneal-
wounding. qRT–PCR data on untreated and wounded corneas
was complemented by immunohistological and Vsx1 knock-
in reporter gene expression studies. Using these approaches,
we failed to detect Vsx1 expression in both untreated and
wounded corneas. Our findings make it uncertain what role,
if any, Vsx1 plays in the mouse cornea.
METHODS
Animals: All experiments on wild type mice were performed
on 129S1 inbred mice (The Jackson Laboratory, Bar Harbor,
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737ME). Vsx1:τLacZ knock-in mice [4] were maintained on a
129S1 genetic background. All mouse work was done with
approval  from  the  University  of  Victoria  Animal  Care
Committee,  in  accordance  with  the  Canadian  Council  for
Animal Care.
RNA extraction: Mice were euthanized by cervical dislocation
and  tissues  dissected  in  chilled  phosphate  buffered  saline
Figure 1. Vsx1 qRT-PCR primer design. Locations of Vsx1 qRT–
PCR primers (see Table 1) on the Vsx1 cDNA (A) and qRT–PCR
samples of wild type mouse retina with Vsx1 primers as well as
Gapdh housekeeping and Rho sets (B) run on a 1.2% agarose gel. In
mRNA schematic: Grey box – homeodomain, open box – CVC
domain.
(PBS), transferred to 2 ml microcentrifuge tubes containing
1 ml Trizol (Invitrogen, Carlsbad, CA) and Precellys CK28
ceramic beads (Precellys, Montigny-le-Bretonneux, France)
and  then  frozen  on  dry  ice.  Tissue  homogenization  was
performed on a Precellys-24 homogenizer using two 10-s
pulses. Homogenized tissue was spun for 10 min at 12,000×
g at 2–8 °C, the supernatant transferred into fresh tubes and
then  kept  at  room  temperature  for  5  min.  Next,  0.2  ml
chloroform was added per ml of Trizol in the initial tubes, the
tubes shaken, left to sit for 3 min at room temperature and then
samples were centrifuged at 12,000× g for 15 min at 2–8 °C.
The upper aqueous phase was then transferred into a fresh
tube, 0.5ml isopropyl alcohol was added and samples were
mixed by shaking. Following 10 min at room temperature and
a 10-min centrifuge at 2–8 °C, 12,000× g, the supernatant was
removed and resulting RNA pellet was washed using 75%
ethanol before being stored in distilled RNase/DNase-free
water (Gibco, Invitrogen,  Carlsbad, CA).
qRT–PCR:  Primers  for  Vsx1  were  designed  using  Primer
3Plus  software  while  those  for  housekeeping  gene
glyceraldehyde-3-phosphate  dehydrogenase  (Gapdh),
myofibroblast marker alpha-smooth muscle actin (Acta2) and
rhodopsin  (Rho)  were  taken  from  the  literature  (Table  1)
[20-22].  Specific  amplification  was  verified  through
comparison  of  PCR  product  sequences  against  published
cDNA  sequences.  Cloning  for  sequencing  was  preformed
using pGEMT Easy Vector protocol (Promega, Madison, WI)
and  QIAprep  Miniprep  kit  (Qiagen  Inc.,  Mississauga,
Ontario).  RT  reactions  were  preformed  as  per  Quantitect
Reverse Transcription kit (Qiagen) protocol and reactions run
as per Quantitect SYBR Green PCR kit (Qiagen): 15 min
95 °C, 35× (15 s 94 °C, 30 s 60 °C, 30 s 72 °C) using a
Stratagene Mx300p (Agilent Technologies, Inc., Santa Clara,
CA). Relative expression between samples was calculated
using the 2-ΔΔCt method [23] using the housekeeping gene
GAPDH to normalize.
TABLE 1. SEQUENCE AND DETAILS OF QRT–PCR PRIMERS.
Gene Primer Sequence Notes
Vsx1 primer pair 1 forward TATGCCCCGTTTTAGTCTGG both primers within exon 5; 143
bp product reverse CCCAAAACAGACAACCCTTC
Vsx1 primer pair 2 forward GGTTTTCACTGCCCATCAAC reverse primer spans exon 3/4
junction; 109 bp product reverse TTCCGGGAGCTCTGTTTTC
Vsx1 primer pair 3 forward TGGGGATGCATAAAAAGTCC forward primer spans 4/5
junction; 146 bp product reverse GTTCTGGGTTGTTTCGTCTG
Gapdh forward TGTGTCCGTCGTGGATCTGA 77 bp product [20]
reverse CCTGCTTCACCACCTTCTTGA
Rho (rhodopsin) forward TTGCCACACTTGGAGGTGAA forward primer spans exon 1/2
junction, 70 bp product [21] reverse ACCACCACGTAGCGCTCAAT
Acta2 (alpha 2-SMA) forward ACTGGGACGACATGGAAAAG 240 bp product [22]
reverse CATCTCCAGAGTCCAGCACA
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738Corneal  wounding  procedure:  Our  alkali-burn  corneal
wounding  protocol  was  based  on  previously  published
protocols [24,25]. Briefly, 4 μl of 0.2 M NaOH was applied
to the corneas of anesthetized mice for 30 s followed by
flushing  with  10  ml  of  saline  solution.  Mice  were  then
euthanized using cervical dislocation at desired time points
post-wounding. Mice undergoing the wounding procedure
were injected subcutaneously with buprenorphine (0.1 mg/kg)
pre-wounding, and every 12 h for up to 3 days after the
procedure to provide analgesia. One drop of Proparacaine was
also applied to eyes immediately before NaOH application as
a topical anesthesia. All mice were monitored throughout the
experiments in accordance with University of Victoria animal
care guidelines.
Immunolabeling: Eyes removed from euthanized mice were
transferred to chilled PBS and bisected longitudinally using
scissors to expose inner ocular chambers. Bisected eyes were
then  fixed  for  1  h  in  4%  paraformaldehyde/PBS  on  ice
followed by washing in PBS and overnight cyroprotection in
30% sucrose/PBS at 4 °C. Tissue was frozen in Tissue-Tek
OCT  (Sakura  Finetek,  Torrance,  CA)  and  sectioned  at  a
thickness  of  14  μm  and  stored  at  −20  °C.  Sections  were
washed with PBS and cleared in 1% Triton X-100/PBS for 30
min. Blocking was performed in 10% horse serum/PBS for 1
h before incubating with primary rabbit anti-Vsx1 antibody
[3]  used  at  a  1:100  dilution  in  1%  horse  serum/PBS.
Secondary labeling was performed using an Alexa-Fluor-488
conjugated donkey anti-rabbit (1:100 in PBS). Nuclei were
stained with Draq-5 (Biostatus, Leicestershire, UK). Slides
were  imaged  using  a  Nikon  confocal  microscope  (Nikon,
Mississauga, Ontario). Post-imaging adjustment of levels in
order to observe non-specific labeling was done in Adobe
Figure 2. Representative Vsx1 qRT-PCR amplification plots. Amplification plots of qRT–PCR of wild type mouse retinal (A) and corneal
(B) samples using primers for Vsx1, Gapdh and Rho shown in Table 1. x-axis shows qRT–PCR cycle number, y-axis shows SYBR-green
fluorescence values.
Figure 3. Expression of Vsx1 in postnatal mouse retinal and corneal samples relative to P21 levels from qRT–PCR. Three animals were used
for each time point. The y-axis shows Vsx1 expression relative to expression on postnatal (P) day 21. x-axis shows postnatal day, tissue, and
Vsx1 primer set number.
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739Photoshop (Adobe Systems Incorporated, San Jose, CA) by
changing the maximum levels value from 256 to 26.
RESULTS
Analysis  of  Vsx1  mRNA  expression  in  the  postnatal  and
mature mouse cornea: To examine Vsx1 mRNA expression,
4 primer pairs spanning Vsx1 exons 3–5 were designed. Only
3  of  these  primer  pairs  (Figure  1A)  robustly  amplified
products from adult (2–8 months old) retinal cDNA of the
predicted size (Figure 1B), with similar efficiencies (Figure
2A) and correct sequence (data not shown). In contrast to the
retina, no qRT–PCR product was observed for any of the 3
Vsx1 primer pairs when amplifying from adult corneal cDNA
(Figure 2 B, n=3 mice). No specific qRT-PCT product was
observed after up to 40 cycles (data not shown).
We next examined retinal and corneal cDNA from wild
type mice over the course of several postnatal time points
(postnatal days 0, 3, 7, 14, and 21; n=3 mice for all time points;
Figure 3). Consistent with the previously described onset of
Vsx1  expression  in  mouse  at  postnatal  day  5,  retinal
expression of Vsx1 was detected in our samples at post-natal
day 7 onward. In contrast, no Vsx1 expression was detected
in any of the corneal samples. Likewise, Rho (which served
as a control for retinal contamination) was absent from the
cornea.
Analysis  of  Vsx1  mRNA  expression  following  corneal
wounding: Corneal wounding experiments were performed
on 8 wild type mice with one eye receiving an alkali burn and
the other serving as an untreated control (4 mice with treated
left eye, 4 with treated right). Wounded corneas appeared
cloudy from 1 day post-wounding. Retinal and corneal tissue
was taken 3 days after the corneal wounding with NaOH and
the wounded morphology of treated corneas was confirmed
through examination during dissection (Figure 4A,B). Alkali
treated corneas were no longer transparent, appeared thicker
and  had  considerably  pitted  surfaces  compared  to  the
unwounded control eyes from the same mouse. qRT–PCR
results found no significant change in Vsx1 expression post-
wounding in the retina samples. Vsx1 expression was not
observed in untreated or alkali-wounded corneal samples but
Acta2,  a  gene  that  is  known  to  be  upregulated  following
corneal alkali burn [25] was significantly unregulated by an
average of 16.3 times in treated relative to untreated control
eyes for both wild type and Vsx1τLacZ/τLacZ mice (Figure 4C). A
time  course  experiment  set-up  identically  to  the  3  day
wounding found no Vsx1 expression in the corneas of wild
Figure 4. Vsx1 qRT-PCR expression is
not  detected  in  the  cornea  following
alkali wounding. orneal wounding was
performed through application of 0.2 M
NaOH,  which  resulted  in  significant
structural changes after 3 days between
untreated  (A)  and  treated  (B)  mouse
eyes.  Relative  expression  of  Vsx1  in
wounded  versus  unwounded  eyes,
normalized to Gapdh, from retinal and
corneal  samples  is  shown  along  with
retinal Rho and Acta2 expression. y-axis
shows  relative  expression  between
wounded and untreated eyes while the
x-axis indicates primer set (Vsx1 sets 1–
3, Acta2, and Rho) and tissue (retinal or
corneal).
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740type mice 6 h, 1 day, 3 days, 7 days or 14 days post-wounding
although Acta2 was upregulated in each case (data not shown).
Histological  examination  of  Vsx1  expression  following
corneal  wounding:  Immunohistological  analysis  aimed  to
confirm the qRT–PCR results in the cornea. No specific Vsx1
Figure 6. Non-specific immunolabeling of alkali-wounded corneas.
Panels A-C correspond to panels I, M, and Q, respectively, from
Figure 5. The image pixel intensity levels have been elevated by an
order of magnitude.
immunolabeling was observed in the corneas of alkali-burn
wounded or untreated mice as compared to Vsx1τLacZ/τLacZ mice,
which do not have Vsx1-immunolabeling [4] and therefore
serve as a negative control (Figure 5). It was noted that when
the post-acquisition imaging pixel intensity level was elevated
by  an  order  of  magnitude  higher  than  the  optimal  near-
saturation levels used for imaging retinal Vsx1, non-specific
labeling was observed in both wild type and Vsx1τLacZ/τLacZ
alkali-burn  treated  corneas  but  not  in  untreated  corneas
(Figure  6).  We  next  examined  β-galactosidase  knock-in
reporter  expression  in  normal  and  wounded  corneas  of
Vsx1τLacZ/τLacZ  mice.  The  Vsx1  τLacZ  knock-in  reporter
recapitulates the normal Vsx1 expression pattern in retinal
bipolar cells [4] and, although it is present in the developing
ventral hindbrain and spinal cord, it is not detected from the
embryonic retina and cornea (Figure 7 and data not shown).
Similar to the non-specific Vsx1 immunolabeling observed in
the  wounded  cornea,  a  high  degree  of  non-specific  β-
galactosidase immunolabeling was also observed in wild type
Figure 5. Vsx1 immunolabeling is not detected in normal or alkali-wounded corneas. sx1 immunolabeling (A, E, I, M, Q) of adult mouse
retina (A-H) and cornea (I-T). Vsx1 immunolabeling of bipolar cells is present in wild type retinal section (A-D) but not in Vsx1τLacZ/τLacZ
mice (E-H). Corneal sections from untreated mice (I-L) and from corneas receiving alkali-burn (M-T) were imaged for Vsx1 immunolabeling
using the same imaging settings as those used for imaging retina. Sections were co-labeled with Draq5 nuclear stain.
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741and  wounded  cornea  (data  not  shown).  We  therefore
examined  β-galactosidase  activity  using  the  X-gal  (5-
bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside)
chromogenic substrate. In contrast to robust β-galactosidase
activity in the Vsx1τLacZ/τLacZ retina, no activity was observed in
wounded or untreated corneas (Figure 8).
DISCUSSION
The role of VSX1/Vsx1 in the corneal dystrophies keratoconus
and  posterior  polymorphism  dystrophy  (PPCD1)  and,  the
issue of whether it is expressed in the cornea has been a subject
of considerable controversy. This study aimed to resolve the
question of corneal Vsx1 expression in mice and evaluate a
possible explanation for the association of VSX1 mutations
with corneal disease.
For qRT–PCR, the use of three different Vsx1 primers
spaced over three of the five exons of the Vsx1 gene, two of
which  were  intron-spanning,  aimed  to  ensure  reliable
detection and reproducibility of any Vsx1 mRNA expression
in samples. Further confidence in these primers was gained
through comparison to previous Vsx1 expression studies. For
example, in this study, postnatal Vsx1 expression in the mouse
retina  was  only  detected  after  postnatal  day  3,  which  is
Figure 7. Vsx1 knock-in reporter gene expression at embryonic day
11.5. X-gal staining of wild type (A) and Vsx1τLacZ/τLacZ (B-D) mouse
embryos  embryonic  day  11.5.  Xgal  staining  is  detected  in  the
developing hindbrain (arrows in B and C) and spinal cord but is not
detected in the developing eye (A, B - arrowhead). D: Cross-section
through the eye of the embryo from panel B shows that ocular
expression is undetectable in the developing retina (r), lens (L) and
corneal region (c). Scale bar in D=50 μm.
consistent  with  Vsx1  expression  detected  by  in  situ
hybridization at post-natal day 5 [3]. In contrast to the very
low levels of VSX1 neonatal expression reported between day
of birth and 9 months of age, we did not observe any Vsx1
corneal expression in the postnatal mouse at stages before and
after eye opening. These findings suggest possible differences
in the role of VSX1/Vsx1 in human and mouse corneal biology.
Our inability to detect any corneal Vsx1 expression in
adult wild-type mouse corneal tissue is consistent with the
results of previous studies [3,7,26] that have failed to detect
Vsx1 corneal expression. We thus investigated whether Vsx1
might be expressed as part of the wound healing response in
the  cornea  as  previously  proposed  [19].  The  significant
upregulation  of  Acta2,  signifying  the  keratocyte  to
myofibroblast  transformation  associated  with  wound
response in the cornea, in addition to the morphology changes
seen in our wounded corneal samples both indicate that the
alkali  insult  was  successful  in  stimulating  the  corneal
wounding  response.  Despite  this  response,  qRT–PCR,
immunolabeling and reporter gene expression revealed no
specific corneal Vsx1/Vsx1 expression in untreated or alkali-
burn damaged corneas at time points ranging from 6 h to 14
days post-wounding. Interestingly, there did appear to be a
slight increase in non-specific labeling in alkali-burn damaged
corneas that was not observed in untreated corneas. However,
since this labeling was also present in Vsx1τLacZ/τLacZ mice,
which lack Vsx1 immunolabeling, this suggests that wounded
corneas are more prone to non-specific labeling than untreated
corneas.  Furthermore,  following  alkali-burn,  no  obvious
changes in the corneal wound response at the histological level
or in the upregulation of Acta2 were observed in Vsx1τLacZ/
Figure 8. Vsx1 knock-in reporter gene expression is not detected in
normal  or  alkali-wounded  corneas.  X-gal  staining  of  retina  (A),
untreated  cornea  (C)  and  alkali-burn  damaged  cornea  (D)  from
Vsx1τLacZ/τLacZ mice as well as the untreated cornea from a wild type
mouse (B).
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742τLacZ  mice,  indicating  that  Vsx1  is  not  essential  for  these
features of the wound response. Our findings call into question
the potential association of Vsx1 with the wound response
pathway in the mouse cornea.
In this study, we show that Vsx1 is not expressed at
detectable levels in the cornea at all stages examined. We
demonstrated that Vsx1 is not detected in the cornea following
alkali-burn damage using qRT–PCR, immunohistology and
Vsx1 knock-in reporter expression. It remains possible that
VSX1/Vsx1 contributes in corneal pathology through a cell
non-autonomous mechanism, however this possibility has yet
not been investigated. Our data suggests that in addition to the
genetic heterogeneity and complexity that has been predicted
for  keratoconus  and  PPCD1,  there  may  also  be  species
differences in role of VSX1/Vsx1 in human and mouse corneal
biology.
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